Chem Structure (Image 01)
Hydralazine Hydrochloride Tablet
Product Images NDC 72162-1538
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 72162-1538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl721621538)
This is a description of a medication called hydralazine hydrochloride tablets, USP. Each tablet contains 100 mg of the active ingredient. It is important to keep this medication out of the reach of children and store it at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should be dispensed in a tight container with a child-resistant closure. The pharmacist should follow the instructions for use provided at https://dailymed.nim.nih.gov/dailymed/. The medication is labeled with the NDC number 72162-1538-1 and the manufacturer is ScieGen Pharmaceuticals Inc. It has been relabeled by Bryant Ranch Prepack, Inc. located in Burbank, CA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
